Platelet-targeted thrombolysis for treatment of acute ischemic stroke

Thrombolysis with tissue-type plasminogen activator (tPA) remains the main treatment for acute ischemic stroke. Nevertheless, tPA intervention is limited by a short therapeutic window, low recanalization rates, and a risk of intracranial hemorrhage (ICH), highlighting the clinical demand for improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Palazzolo, Jason S., Ale, Anukreity, Ho, Heidi, Jagdale, Shweta, Broughton, Brad R. S., Medcalf, Robert L., Wright, David K., Alt, Karen, Hagemeyer, Christoph E., Niego, Be’eri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984306/
https://www.ncbi.nlm.nih.gov/pubmed/35482909
http://dx.doi.org/10.1182/bloodadvances.2021006691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984306/
https://www.ncbi.nlm.nih.gov/pubmed/35482909
http://dx.doi.org/10.1182/bloodadvances.2021006691

Ejemplares similares